Congressional appropriations package expands reporting obligations for PBMs to increase transparency. It also delinks PBM ...

Opening up about drug pricing decisions is not optional for biopharma anymore. For the sake of credibility, companies should ...

Independent observational case series of LTR Pharma’s intranasal erectile dysfunction spray Spontan reports positive outcomes ...

InnoCare Pharma Ltd recently said that, driven by robust sales of its flagship anti-cancer drug and income from overseas licensing agreements, it expects to more than double its revenue in 2025 and ...

Roche is continuing its return to the RNA space by paying $200 million for the worldwide license to one of SanegeneBio’s ...

Hiplife star Mr Oduro has reemerged as Dr Oduro after earning a pharmacy doctorate in the US, advocating for health and wellness while captivating Ghanaians online.

As this complexity deepens, a simple truth emerges: classical measurement frameworks cannot keep pace with a system that is no longer linear, nor even merely non-linear, but fundamentally ...

Sanofi’s pipeline features a number of once-hyped candidates that are struggling to deliver in the clinic, and the ...

A ceiling “maximum fair price” established by the Inflation Reduction Act will end up being an important driver of ...

Community pharmacists say this could be the straw that breaks the camel's back because it's the latest in a raft of changes in a sector that is fighting t ...

The All India Organisation of Chemists and Druggists (AIOCD) has welcomed the Union Budget 2026-27, calling it a ...

Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...